GHRP-2

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Price range: $34.99 through $48.99

SKU: 214412-1-1-5-1-4-1-2-2-1-9-1-2 Category:
  • Official retailer
  • Quality guaranteed
  • Within 2 Days Delivery
  • 99% Purified

Purity You Can Trust. Results You Can Feel.

Shop Peptides Direct offers premium-grade, third-party tested peptides for research and peak performance. Experience uncompromising quality with fast, discreet shipping nationwide.

High-Level Summary

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide belonging to the class ofย growth hormone secretagogues. It is widely studied in laboratory environments for its interaction with theย growth hormone secretagogue receptor (GHS-R)ย and its ability to stimulate signaling pathways associated with endogenous growth hormone release.

GHRP-2 functions as a ghrelin receptor agonist and has been used extensively in experimental models examiningย endocrine signaling, metabolic regulation, and neuroendocrine pathway interactions. Because of its receptor activity, it has become a valuable tool in research exploring hormone secretion patterns and feedback mechanisms within the hypothalamic-pituitary axis.

In controlled laboratory studies, GHRP-2 has been used to investigate:

  • Growth hormone secretion models
    โ€ข Ghrelin receptor signaling pathways
    โ€ข Endocrine feedback regulation
    โ€ข Metabolic pathway interaction with hormonal signaling
    โ€ข Appetite-associated signaling research

Its relatively short peptide sequence and well-characterized receptor activity make it a commonly studied compound in experimental endocrine models.

Product Details

Form: Lyophilized peptide powder
Peptide Class: Hexapeptide growth hormone secretagogue
Purity: โ‰ฅ99% (analytically verified)
CAS Number: 158861-67-7
Peptide ID: LP-G2-15
Certificate of Analysis: Available upon request
Intended Use: Laboratory research only

Mechanism of Action (MOA)

GHRP-2 acts primarily through activation of theย growth hormone secretagogue receptor (GHS-R1a), a receptor also targeted by the endogenous hormone ghrelin.

When GHRP-2 binds to this receptor in experimental models, it can initiate signaling cascades associated with growth hormone release from the anterior pituitary. This receptor interaction also engages multiple intracellular signaling pathways involved in endocrine regulation.

Ghrelin Receptor Activation

GHRP-2 functions as an agonist of the GHS-R receptor, a receptor found in the hypothalamus and pituitary. Activation of this receptor in laboratory models can stimulate pathways involved in hormone secretion.

Endocrine Signaling Pathways

Research models show that GHRP-2 interacts with signaling systems that regulate hormone release, including pathways related to hypothalamic and pituitary communication.

Metabolic Signaling Research

Because growth hormone plays an important role in metabolic regulation, GHRP-2 has also been studied in laboratory environments examining metabolic pathway signaling and endocrine-metabolic interactions.

Appetite Signaling Models

Ghrelin receptor agonists such as GHRP-2 have also been studied in research involving appetite signaling pathways and energy regulation models.

These mechanistic properties make GHRP-2 useful in controlled experimental settings investigating hormone signaling networks.

Research Applications

GHRP-2 is commonly utilized in laboratory studies investigating:

  • Growth hormone secretion models
    โ€ข Hypothalamic-pituitary axis research
    โ€ข Ghrelin receptor signaling pathways
    โ€ข Metabolic hormone interaction studies
    โ€ข Appetite signaling mechanisms
    โ€ข Neuroendocrine pathway investigation

Researchers are responsible for designing experimental protocols and ensuring compliance with applicable laboratory regulations.

Structural Characteristics

GHRP-2 is aย synthetic hexapeptide, meaning it contains six amino acids arranged in a specific sequence designed to interact with the growth hormone secretagogue receptor.

Its molecular structure allows it to mimic certain aspects of ghrelin receptor activation, enabling researchers to investigate receptor-mediated signaling responses in experimental models.

The peptideโ€™s compact structure contributes to its stability and usefulness in laboratory endocrine research.

Product Specifications

Form: Lyophilized powder
Purity: โ‰ฅ99% analytical verification
Peptide Class: Growth hormone secretagogue hexapeptide
CAS Number: 158861-67-7
Peptide ID: LP-G2-15
Packaging: Sterile research vial
Storage: Refrigerated (2โ€“8ยฐC)

Quality Assurance & Testing

Each batch of GHRP-2 undergoes analytical verification to ensure research-grade quality and consistency.

Quality verification procedures may include:

  • High-Performance Liquid Chromatography (HPLC) purity testing
    โ€ข Identity confirmation analysis
    โ€ข Batch traceability documentation
    โ€ข Controlled lyophilization procedures
    โ€ข Sterile packaging verification

Certificates of Analysis are available upon request.

Handling & Storage Guidelines

GHRP-2 is supplied as aย lyophilized powderย intended for laboratory research environments.

Recommended storage conditions:

  • Store refrigerated atย 2โ€“8ยฐC
    โ€ข Protect from direct light exposure
    โ€ข Avoid repeated temperature cycling
    โ€ข Handle using proper laboratory techniques

The peptide is supplied dry and is not pre-reconstituted.

Legal & Compliance Notice

This product is intended strictly forย laboratory research purposes only.

Not for human consumption.
Not for veterinary use.
Not for therapeutic or diagnostic applications.

By purchasing this product, the buyer acknowledges compliance with all applicable laws and research regulations.

What is GHRP-2?

GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide growth hormone secretagogue studied in laboratory environments for its interaction with ghrelin receptors and endocrine signaling pathways.

What type of peptide is GHRP-2?

GHRP-2 belongs to a class of peptides known asย growth hormone secretagogues, which are compounds investigated for their ability to stimulate growth hormone signaling pathways in experimental models.

What form does your GHRP-2 come in?

Our GHRP-2 is supplied as aย sterile lyophilized powderย intended for laboratory research applications.

What is the CAS number for GHRP-2?

The CAS number for GHRP-2 isย 158861-67-7.

Is GHRP-2 intended for human use?

No. GHRP-2 is intended strictly forย laboratory research purposes only.

How should GHRP-2 be stored?

Store GHRP-2 refrigerated atย 2โ€“8ยฐC, protected from light, and handled according to laboratory best practices.

What purity standard is GHRP-2 produced to?

Each batch is analytically verified toย โ‰ฅ99% purityย and supported by batch documentation and COA availability.

How do I request a Certificate of Analysis?

Certificates of Analysis can be requested by contacting support and referencing your order information.

GHRP-2 Dosage Protocol (5 mg & 10 mg Vials)

Quickstart Highlights

GHRP-2 (pralmorelin) is a synthetic hexapeptide that potently stimulates growth hormone release by activating ghrelin receptors in the pituitary and hypothalamus[1][2]. It has been used in clinical research as a diagnostic GH stimulant and in investigative treatment protocols for growth hormone deficiency[3]. This educational protocol presents a onceโ€‘daily subcutaneous approach using practical dilutions for clear insulinโ€‘syringe measurements.

  • Multiple vial sizes: Choose from 5 mg or 10 mg vials to match your protocol needs.
  • Daily dose range: 100โ€“300 mcg (0.1โ€“0.3 mg) once daily (gradual escalation protocol).
  • Convenient dosing: Each vial size has optimized reconstitution for easy insulin syringe measurements.
  • Storage: Lyophilized: freeze at โˆ’20 ยฐC (โˆ’4 ยฐF); after reconstitution, refrigerate at 2โ€“8 ยฐC (35.6โ€“46.4 ยฐF) and use within 28 days.

Dosing & Reconstitution Guide

Educational guide for all vial sizes - choose your optimal concentration

5 mg Vial Protocol (3 mL = ~1.67 mg/mL)

Week Daily Dose Units (per injection) (mL)
Weeks 1โ€“2 100 mcg (0.1 mg) 6 units (0.06 mL)
Weeks 3โ€“4 150 mcg (0.15 mg) 9 units (0.09 mL)
Weeks 5โ€“8 200 mcg (0.2 mg) 12 units (0.12 mL)
Weeks 9โ€“12 200 mcg (0.2 mg) 12 units (0.12 mL)
Weeks 13โ€“16 200 mcg (0.2 mg) 12 units (0.12 mL)

Reconstitution: Add 3.0 mL bacteriostatic water โ†’ ~1.67 mg/mL concentration. At this concentration, 1 unit = 0.01 mL โ‰ˆ 16.7 mcg on a Uโ€‘100 insulin syringe. Ideal for low-volume daily dosing. For โ‰ค10-unit (โ‰ค0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

10 mg Vial Protocol (3 mL = ~3.33 mg/mL)

Week Daily Dose Units (per injection) (mL)
Weeks 1โ€“2 100 mcg (0.1 mg) 3 units (0.03 mL)
Weeks 3โ€“4 150 mcg (0.15 mg) 4.5 units (0.045 mL)
Weeks 5โ€“8 200 mcg (0.2 mg) 6 units (0.06 mL)
Weeks 9โ€“12 200 mcg (0.2 mg) 6 units (0.06 mL)
Weeks 13โ€“16 200 mcg (0.2 mg) 6 units (0.06 mL)

Reconstitution: Add 3.0 mL bacteriostatic water โ†’ ~3.33 mg/mL concentration. At this concentration, 1 unit = 0.01 mL โ‰ˆ 33.3 mcg on a Uโ€‘100 insulin syringe. More concentrated for smaller injection volumes. For โ‰ค10-unit (โ‰ค0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps (All Vial Sizes)

  1. Draw appropriate volume of bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall to minimize foaming; avoid shaking.
  3. Gently swirl or roll the vial until the powder is fully dissolved.
  4. Label the vial with the reconstitution date and refrigerate at 2โ€“8 ยฐC (35.6โ€“46.4 ยฐF), protected from light.
  5. Use reconstituted solution within 28 days for maximum potency and safety[8].

Supplies Needed

Plan based on an 8โ€“16 week daily protocol with gradual titration.

  • Peptide Vials (GHRP-2): Choose your preferred vial size (5 mg or 10 mg).
  • Insulin Syringes (Uโ€‘100, 1 mL): For โ‰ค10-unit doses, 30โ€‘ or 50โ€‘unit syringes recommended for precision.
    • Per week: 7 syringes (1/day)
    • 8 weeks: 56 syringes
    • 12 weeks: 84 syringes
    • 16 weeks: 112 syringes
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
    • 8 weeks (5 mg: 2 vials / 10 mg: 1 vial): 6 mL or 3 mL โ†’ 1 ร— 10 mL bottle
    • 12 weeks (5 mg: 4 vials / 10 mg: 2 vials): 12 mL or 6 mL โ†’ 2 ร— 10 mL or 1 ร— 10 mL bottles
    • 16 weeks (5 mg: 5 vials / 10 mg: 3 vials): 15 mL or 9 mL โ†’ 2 ร— 10 mL or 1 ร— 10 mL bottles
  • Alcohol Swabs: One for the vial stopper + one for the injection site each day.
    • Per week: 14 swabs (2/day)
    • 8 weeks: 112 swabs โ†’ recommend 2 ร— 100โ€‘count boxes
    • 12 weeks: 168 swabs โ†’ recommend 2 ร— 100โ€‘count boxes
    • 16 weeks: 224 swabs โ†’ recommend 3 ร— 100โ€‘count boxes
  • Sharps Container: 1โ€‘quart container holds ~100 syringes; 2โ€‘quart for longer protocols.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Protocol Overview

Concise summary of the onceโ€‘daily regimen.

  • Goal: Stimulate endogenous growth hormone secretion through ghrelin receptor activation[1].
  • Schedule: Daily subcutaneous injections for 8โ€“12 weeks (extend to 16 weeks if desired).
  • Dose Range: 100โ€“300 mcg daily with gradual titration; higher doses show dose-dependent responses but may offer limited added benefit with routine use[4].
  • Vial Options: 5 mg or 10 mg vials with optimized reconstitution for each size.
  • Storage: Lyophilized frozen at โˆ’20 ยฐC (โˆ’4 ยฐF); reconstituted refrigerated at 2โ€“8 ยฐC (35.6โ€“46.4 ยฐF); use within 28 days.

Dosing Protocol

Suggested daily titration approach based on clinical studies[2][3][4].

  • Weeks 1โ€“2: 100 mcg once daily to establish baseline tolerance.
  • Weeks 3โ€“4: 150 mcg once daily to enhance GH response if well tolerated.
  • Weeks 5โ€“16: 200 mcg once daily for maximal effect in most research scenarios; advanced researchers may optionally increase to 250โ€“300 mcg.
  • Frequency: Once per day (subcutaneous); evening administration may align with nocturnal GH rhythms.
  • Cycle Length: 8โ€“16 weeks; some attenuation may occur in first 1โ€“2 weeks but response stabilizes with continued dosing[3].

Storage Instructions

Proper storage preserves peptide quality and efficacy[8][9].

  • Lyophilized (powder): Store at โˆ’20 ยฐC (โˆ’4 ยฐF) in dry, dark conditions; stable at room temperature for short periods but freezer storage maximizes shelf life[8].
  • Reconstituted (solution): Refrigerate at 2โ€“8 ยฐC (35.6โ€“46.4 ยฐF) and do not freeze; use within 28 days for maximum potency[9].
  • Shelf life: Use reconstituted solution within 28 days; the benzyl alcohol in bacteriostatic water inhibits bacterial growth but solutions should still be discarded after approximately 4 weeks.
  • Allow vials to reach room temperature before opening to minimize condensation uptake. Always protect from light and heat.

Important Notes

Practical considerations for consistency and safety.

  • Use new sterile insulin syringes for each injection; dispose in a proper sharps container[10].
  • Rotate injection sites systematically (abdomen, thighs, upper arms) to reduce local irritation and avoid lipodystrophy[13].
  • Very frequent dosing (e.g., every 2 hours) can cause progressive attenuation due to acute tachyphylaxis[3]; once-daily administration avoids this issue.
  • Multiple daily injections (2โ€“3ร—) have been explored but require strict adherence and may offer limited added benefit[5][6].
  • Document daily dose and site rotation to maintain consistency.
  • A 5โ€‘daysโ€‘on/2โ€‘daysโ€‘off schedule may help maintain GH response sensitivity over long protocols[7].

How This Works

GHRP-2 is a synthetic growth hormone secretagogue that binds to and activates ghrelin (GHS-R1a) receptors[1]. By binding to receptors in both the pituitary and hypothalamus, it triggers robust, pulsatile GH release that mimics natural secretion patterns[2]. Clinical studies have demonstrated that even a single 100 mcg subcutaneous dose can raise GH levels severalโ€‘fold above baseline[4]. When administered consistently, GHRP-2 can elevate IGFโ€‘1 levels over weeks to months (~50% increase reported in some studies)[5]. However, the GH response may attenuate with continuous daily use (tachyphylaxis), which is why titration strategies and periodic breaks are often incorporated[4][7]. The peptide has been well tolerated in clinical trials with no significant adverse effects or toxicity reported at these dosage ranges[2][7].

Potential Benefits & Side Effects

Observations from clinical and preclinical literature[1][2][3][4][5][6][7].

Potential Benefits:

  • Potent GH stimulation: Robust, pulsatile release without suppressing natural production[1].
  • IGFโ€‘1 elevation: Sustained administration can significantly increase IGFโ€‘1 levels[5].
  • Clinical diagnostic use: Used as a diagnostic tool for GH deficiency evaluation[3].
  • Combination therapy: In combination with GHRH analogs, can further amplify GH/IGFโ€‘1 axis[5][6].
  • Generally well tolerated: Placebo-like safety profile in clinical studies[7].

Potential Side Effects:

  • Increased appetite (most common): Ghrelinโ€‘mimetic action, especially shortly after injection[1].
  • Injectionโ€‘site reactions: Mild redness, irritation (generally transient).
  • Transient effects: Mild flushing, warmth, or tingling.
  • Possible mild hormonal increases: Cortisol and prolactin at higher doses[6].
  • Response attenuation: Tachyphylaxis with continuous daily dosing[4].
  • High-dose effects: Water retention or joint stiffness with prolonged highโ€‘dose use (โ‰ฅ300 mcg/day).

Lifestyle Factors

Complementary strategies for optimal outcomes.

  • Administer on an empty stomach or before sleep to optimize GH pulse amplitude.
  • Maintain adequate protein intake and balanced nutrition to support the anabolic effects of elevated GH.
  • Combine resistance training and aerobic activity to support body composition benefits.
  • Prioritize 7โ€“9 hours of quality sleep to synergize with natural nocturnal GH secretion.
  • Manage stress effectively, as elevated cortisol can blunt GH response.
  • Stay well hydrated to support metabolic processes.

Injection Technique

General subcutaneous guidance from clinical bestโ€‘practice resources[10][11][12].

  • Clean the vial rubber stopper and chosen skin site with separate alcohol swabs; allow both to dry completely before proceeding[11].
  • Use a fine insulin syringe (typically 29โ€“31 gauge, 0.5โ€‘inch needle). For โ‰ค10โ€‘unit doses, 30โ€‘ or 50โ€‘unit syringes improve readability.
  • Pinch a fold of skin (abdomen, thigh, or outer upper arm); insert needle at a 45โ€“90ยฐ angle into subcutaneous tissue (fatty layer, not muscle)[10][12]. (Use 90ยฐ angle if ample fatty tissue; 45ยฐ for leaner individuals.)
  • Do not aspirate (pull back the plunger) when giving a subcutaneous injection โ€” aspiration is unnecessary and can cause tissue trauma[10].
  • Inject the solution slowly and steadily; wait a few seconds after injection before withdrawing the needle to ensure complete delivery and minimize leakage.
  • Withdraw the needle and apply light pressure with a clean swab; avoid rubbing vigorously.
  • Rotate injection sites systematically with each daily injection to prevent lipodystrophy โ€” space injections at least 1 inch apart[13].
  • Dispose of used syringes and needles immediately in a proper FDAโ€‘approved sharps container[12].

Recommended Source

We recommend Pure Lab Peptides for highโ€‘purity GHRP-2 in both vial sizes (5 mg and 10 mg).

Why Pure Lab Peptides?

  • Highโ€‘purity, thirdโ€‘partyโ€‘tested peptides with batchโ€‘specific Certificates of Analysis (COAs).
  • Consistent, ISOโ€‘aligned handling and quality documentation.
  • Reliable fulfillment with coldโ€‘chain integrity to preserve peptide stability.
  • Transparent testing and verification processes for researchโ€‘grade peptides.
  • Multiple vial sizes to match different protocol needs and durations.

Important Note

This content is for educational purposes only and is not medical advice. GHRP-2 is for research use only. Not for human consumption. Always consult with qualified professionals before starting any peptide research protocol.

References

  • Domest Anim Endocrinol โ€“ Effects of GHRP-2 on GH release โ€” Mechanism and receptor activation in swine
  • J Clin Endocrinol Metab โ€“ GHRP-2 in GH-deficient children โ€” Eight months treatment with graded doses
  • Eur J Endocrinol โ€“ Fiveโ€‘day GHRP-2: attenuation and IGFโ€‘I โ€” Response attenuation in healthy young men
  • Endocrine โ€“ GH/IGFโ€‘1 response to GHRP-2 in older adults โ€” Acute and chronic effects
  • Am J Menโ€™s Health โ€“ GH secretagogue raises IGFโ€‘1 โ€” ~50% increase over 3 months in hypogonadal men
  • Sex Med Rev (PMC) โ€“ Safety and efficacy of GH secretagogues โ€” Comprehensive review
  • Asian-Australas J Anim Sci โ€“ Twiceโ€‘daily GHRP-2 effects โ€” IGFโ€‘1 and tachyphylaxis patterns
  • Sigma-Aldrich โ€“ Peptide storage guidelines โ€” Lyophilized storage at โˆ’20 ยฐC; reconstituted use within 4 weeks
  • Mountainside Medical โ€“ Bacteriostatic Water guidelines โ€” Multiโ€‘dose vial guidelines; 28โ€‘day use recommendation
  • Usach I. et al. (2019) โ€“ Subcutaneous injection technique โ€” Factors influencing pain and proper technique
  • MedlinePlus โ€“ Subcutaneous (SQ) Injections โ€” Site selection, angle guidance, rotation best practices
  • CDC โ€“ Vaccine Administration: Subcutaneous Route โ€” Clinical guidelines for angle, site selection, noโ€‘aspiration
  • Medicine LibreTexts โ€“ Site rotation and lipodystrophy prevention โ€” Subcutaneous injection best practices
  • Pure Lab Peptides โ€“ GHRP-2 product page โ€” Quality documentation and batch COAs

Reviews

There are no reviews yet.

Be the first to review “GHRP-2”

Your email address will not be published. Required fields are marked *

RELATED PRODUCTS